Similar study results were described by Bunck et al. [25] who, after a 12-month therapeutic period with insulin glargine, did not confirm the increase in the leptin concentration in the plasma of sick individuals with type 2 diabetes. Here, LEP is linked to type 2 diabetes mellitus.